OS2.1 Immune responses to a mutation-specific peptide vaccine targeting IDH1R132H in patients with IDH1R132H-mutated gliomas

Immunotherapeutic concepts for brain tumors have been hampered by lack of selective measures to target the CNS and lack of truly tumor-specific antigens. But the concept of an immune privileged CNS has to be questioned due to survey of the brain by specific T-cells, CNS autoimmunity and presence of...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Neuro Oncol
Hoofdauteurs: Bunse, T., Bunse, L., Sahm, F., Omokoko, T., Stevanovic, S., Deimling, A. von, Sahin, U., Schmitt, M., Wick, W., Platten, M.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Oxford University Press 2016
Onderwerpen:
OS2 Immunology
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5782511/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now188.011
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items